XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 36 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $35,000 | -84.1% | 14,424 | -73.3% | 0.00% | – |
| Q2 2021 | $220,000 | +77.4% | 54,115 | +97.1% | 0.00% | – |
| Q1 2021 | $124,000 | +113.8% | 27,449 | +132.3% | 0.00% | – |
| Q4 2020 | $58,000 | -90.4% | 11,815 | -88.4% | 0.00% | – |
| Q3 2020 | $602,000 | +1368.3% | 101,499 | +554.9% | 0.00% | – |
| Q2 2020 | $41,000 | +215.4% | 15,499 | +124.8% | 0.00% | – |
| Q1 2020 | $13,000 | -75.0% | 6,895 | -5.8% | 0.00% | – |
| Q4 2019 | $52,000 | -48.5% | 7,317 | -28.6% | 0.00% | – |
| Q3 2019 | $101,000 | +48.5% | 10,246 | +72.3% | 0.00% | – |
| Q2 2019 | $68,000 | -63.0% | 5,948 | -67.4% | 0.00% | – |
| Q1 2019 | $184,000 | +114.0% | 18,263 | +261.4% | 0.00% | – |
| Q4 2018 | $86,000 | +405.9% | 5,054 | +424.3% | 0.00% | – |
| Q3 2018 | $17,000 | – | 964 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |